The British government decided on Monday not to inoculate most children and teenagers against COVID-19 until more data on the available vaccines becomes available.
Children as young as 12 with severe neuro-disabilities, Down Syndrome, immunosuppression and multiple or severe learning disabilities, as well as those who are household contacts of individuals who are immunosuppressed, will be eligible for vaccination, the government said.
The decision to hold off giving shots to most people under age 18 was based on the recommendation of an expert advisory panel. The Joint Committee on Vaccination and Immunisation said the health benefits of universal vaccination don't outweigh the risks for most young people, who typically suffer only mild symptoms of the virus.
"Today's advice does not recommend vaccinating under-18s without underlying health conditions at this point in time, Health Secretary Sajid Javid said in a statement. But the JCVI will continue to review new data, and consider whether to recommend vaccinating under-18s without underlying health conditions at a future date.''
The move puts the UK at odds with France and several other European countries, which have decided to vaccinate adolescents as young as 12.
Among hundreds of people at a Paris vaccination center Friday, scores were teenagers with their parents. The French government announced last week that it plans to set up vaccine drives at middle schools, high schools and universities in the fall.
Children and teenagers who are eligible in the UK will receive the Pfizer-BioNTech vaccine, the only one the country has authorized for use in that age group.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)